Market Overview

Deutsche Bank Reiterates Buy Rating on Biogen, PT $240.00 On Upside From Quick-Start Program and Inventory

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BIIB

DateFirmActionFromTo
Jul 2017UBSMaintainsNeutral
Jul 2017Goldman SachsUpgradesNeutralBuy
Jul 2017JefferiesAssumesHold

View More Analyst Ratings for BIIB
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Reiteration Analyst Ratings

 

Related Articles (BIIB)